ALK and interstitial lung disease: Meanwhile, the risks of ILD associated with ALK inhibitors in combination with acetaminophen, amlodipine, lansoprazole, magnesium oxide, metoclopramide, oxycodone, and pantoprazole were higher than the risks of ALK inhibitor monotherapy (Figure 5).